In conclusion, this study is the first to confirm that human pancreatic cancer cells and tissues have decreased expressed of TMEM170B, which suggests that TMEM170B can serve as an independent prognostic predictor following surgery in patients with PAAD. The gene discussed is TMEM170B; the disease is pancreatic adenocarcinoma.